Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bacterial Infections and Mycoses

  Free Subscription

Articles published in
Antimicrob Agents Chemother
    November 2017
  1. TRUONG J, Veillette JJ, Forland SC
    Outcomes of vancomycin plus a beta-lactam versus vancomycin only for the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01554.
    >> Share

  2. DENTI P, Garcia-Prats AJ, Draper HR, Wiesner L, et al
    Levofloxacin population pharmacokinetics in South African children treated for multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01521.
    >> Share

  3. VAN DER LAAN LE, Garcia-Prats AJ, Schaaf HS, Tikiso T, et al
    Pharmacokinetics and drug-drug interactions of lopinavir/ritonavir administered with first and second-line antituberculosis drugs in HIV-infected children treated for multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.00420.
    >> Share

  4. EL-HOSSARY EM, Forstner KU, Francois P, Baud D, et al
    A Novel Mechanism of Inactivating Antibacterial Nitro Compounds in the Human Pathogen Staphylococcus aureus by Overexpression of a NADH-dependent Flavin Nitroreductase.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01510.
    >> Share

  5. HEYCKENDORF J, Andres S, Koser CU, Olaru ID, et al
    What is resistance? Impact of phenotypic versus molecular drug resistance testing on multi- and extensively drug-resistant tuberculosis therapy.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01550.
    >> Share

  6. CHANDRA J, Ghannoum MA
    CD101, a Novel Echinocandin Possesses Potent Anti-biofilm Activity Against Early and Mature Candida albicans Biofilms.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01750.
    >> Share

  7. BELLEY A, Arhin FA, Moeck G
    Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an in vitro Pharmacokinetic/Pharmacodynamic Model.
    Antimicrob Agents Chemother. 2017 Nov 6. pii: AAC.01873.
    >> Share

  8. GARDNER SG, Marshall DD, Daum RS, Powers R, et al
    Metabolic Mitigation of Staphylococcus aureus Vancomycin Intermediate-Level Susceptibility.
    Antimicrob Agents Chemother. 2017 Nov 6. pii: AAC.01608.
    >> Share

    October 2017
  9. SUN Q, Xiao TY, Liu HC, Zhao XQ, et al
    Mutations within embCAB are associated with variable level of ethambutol resistance in Mycobacterium tuberculosis isolates from China.
    Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.01279.
    >> Share

  10. REFOS JM, Vonk AG, Ten Kate MT, Verbrugh HA, et al
    Chitinase induction prior to caspofungin treatment of experimental invasive aspergillosis in neutropenic rats does not enhance survival.
    Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.00960.
    >> Share

  11. WILLBY MJ, Wijkander M, Havumaki J, Johnson K, et al
    Detection of Mycobacterium tuberculosis pncA mutations by the NIPRO GenoscholarPZA-TB II as compared to conventional sequencing.
    Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.01871.
    >> Share

  12. ARGUDIN MA, Roisin S, Dodemont M, Nonhoff C, et al
    Mutations at the ribosomal S10 gene in clinical strains of Staphylococcus aureus with reduced susceptibility to tigecycline.
    Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.01852.
    >> Share

  13. BERUBE BJ, Parish T
    Combinations of respiratory chain inhibitors have enhanced bactericidal activity against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01677.
    >> Share

  14. GENESTET C, Ader F, Pichat C, Lina G, et al
    Combined Antibacterial Effect of Isoniazid and Rifampicin on Four Mycobacterium tuberculosis Strains: in Vitro Experiments and Response-Surface Modeling.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01413.
    >> Share

  15. SAPUTO S, Faustoferri RC, Quivey RG Jr
    Vitamin D compounds are bactericidal against Streptococcus mutans and target the bacitracin-associated efflux system.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01675.
    >> Share

  16. HOLTAPPELS M, Swinnen E, De Groef L, Wuyts J, et al
    The antifungal activity of oleylphosphocholine (OlPC) on in vitro and in vivo Candida albicans biofilms.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01767.
    >> Share

  17. SAPUTO S, Faustoferri RC, Quivey RG Jr
    A drug repositioning approach reveals Streptococcus mutans is susceptible to a diverse range of established antimicrobials and non-antibiotics.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01674.
    >> Share

  18. ACCOCEBERRY I, Rougeron A, Biteau N, Chevrel P, et al
    A CTG clade Candida yeast genetically engineered for the genotype-phenotype characterization of azole antifungal resistance in human pathogenic yeasts.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01483.
    >> Share

  19. BHARDWAJ P, Hans A, Ruikar K, Guan Z, et al
    Reduced chlorhexidine and daptomycin susceptibility in vancomycin-resistant Enterococcus faecium after serial chlorhexidine exposure.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01235.
    >> Share

  20. JONES D, Elshaboury RH, Munson E, Dilworth TJ, et al
    A Retrospective Analysis of Treatment and Clinical Outcomes among Patients with Methicillin-susceptible Staphylococcus aureus Bloodstream Isolates Possessing Detectable mecA by a Commercial PCR Assay Compared to Patients with Methicillin-resistant Sta
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01396.
    >> Share

  21. XU J, Tasneen R, Peloquin CA, Almeida DV, et al
    Verapamil increases the bioavailability and efficacy of bedaquiline but not clofazimine in a murine model of tuberculosis.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01692.
    >> Share

  22. RAFFETIN A, Courbin V, Jullien V, Dannaoui E, et al
    In vitro combination of Isavuconazole with Echinocandins against Azole-Susceptible and -Resistant Aspergillus spp.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01382.
    >> Share

  23. DE WELZEN L, Eldholm V, Maharaj K, Manson AL, et al
    Whole transcriptome and genomic analysis of extensively drug-resistant Mycobacterium tuberculosis clinical isolates identifies downregulation of ethA as a mechanism of ethionamide resistance.
    Antimicrob Agents Chemother. 2017 Oct 9. pii: AAC.01461.
    >> Share

  24. MOUSAVI SF, Pana M, Feizabadi M, Jalali P, et al
    Diversity of mosaic pbp2x families of penicillin-resistant Streptococcus pneumoniae from Iran and Romania.
    Antimicrob Agents Chemother. 2017 Oct 2. pii: AAC.01535.
    >> Share

  25. NAKATANI Y, Opel-Reading HK, Merker M, Machado D, et al
    Role of alanine racemase mutations in Mycobacterium tuberculosis D-cycloserine resistance.
    Antimicrob Agents Chemother. 2017 Oct 2. pii: AAC.01575.
    >> Share

  26. HEALEY KR, Nagasaki Y, Zimmerman M, Kordalewska M, et al
    The gastrointestinal tract is a major source of echinocandin drug resistance in a murine model of Candida glabrata colonization and systemic dissemination.
    Antimicrob Agents Chemother. 2017 Oct 2. pii: AAC.01412.
    >> Share

    September 2017
  27. LIU BH, Lei CW, Zhang AY, Pan Y, et al
    Co-location of the multiresistance gene cfr and the fosfomycin resistance gene fosD on a novel plasmid in Staphylococcus arlettae from chicken farm.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01388.
    >> Share

  28. BUIL JB, van der Lee HAL, Rijs AJMM, Zoll J, et al
    AGAR-BASED SCREENING FOR AZOLE RESISTANCE IN ASPERGILLUS FUMIGATUS USING VIPcheck: A SINGLE CENTRE EVALUATION.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01250.
    >> Share

  29. DESAI AV, Kovanda LL, Hope WW, Andes D, et al
    Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01034.
    >> Share

  30. JIMENEZ-ORTIGOSA C, Moore C, Denning DW, Perlin DS, et al
    Emergence of Echinocandin Resistance due to a Point Mutation in the fks1 Gene of Aspergillus fumigatus in a Patient with Chronic Pulmonary Aspergillosis.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01277.
    >> Share

  31. XU W, DeJesus MA, Rucker N, Engelhart CA, et al
    Chemical genomic interaction profiling reveals determinants of intrinsic antibiotic resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01334.
    >> Share

  32. BERNAL-MARTINEZ L, Gil H, Rivero-Menendez O, Gago S, et al
    Development and validation of a High Resolution Melting Assay to detect azole resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01083.
    >> Share

  33. KIDWAI S, Park CY, Mawatwal S, Tiwari P, et al
    The dual mechanism of action of 5-Nitro-1,10-Phenanthroline against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.00969.
    >> Share

  34. PARK YN, Srikantha T, Daniels KJ, Jacob MR, et al
    A Protocol For Identifying Natural Agents That Selectively Affect Adhesion, Thickness, Architecture, Cellular Phenotypes, ECM and Human White Cell Impenetrability of Candida albicans Biofilms.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01319.
    >> Share

  35. KONG EF, Tsui C, Kucharikova S, Van Dijck P, et al
    Modulation of Staphylococcus aureus Response to Antimicrobials by the Candida albicans Quorum Sensing Molecule Farnesol.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01573.
    >> Share

  36. METCALFE JZ, Streicher E, Theron G, Colman RE, et al
    Mycobacterium tuberculosis subculture results in loss of potentially clinically relevant heteroresistance.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.00888.
    >> Share

  37. NEGRI CE, Goncalves SS, Sousa ACP, Bergamasco MD, et al
    Triazole resistance is still not emerging in A fumigatus isolates causing invasive aspergillosis in Brazilian patients.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.00608.
    >> Share

  38. HOBDEY SE, Katahira EJ, Dockstader P, Davidson SM, et al
    Subinhibitory Dalbavancin Attenuates Exotoxin Production from Methicillin-sensitive and Methicillin-resistant Staphylococcus aureus in vitro.
    Antimicrob Agents Chemother. 2017 Sep 5. pii: AAC.01090.
    >> Share

  39. WOOD JB, Jones LS, Soper NR, Nagarsheth M, et al
    Commercial Intravenous Immunoglobulin (IVIg) Preparations Contain Functional Neutralizing Antibodies Against the Staphylococcus aureus Leukocidin LukAB (LukGH).
    Antimicrob Agents Chemother. 2017 Sep 5. pii: AAC.00968.
    >> Share

  40. HUSZAR S, Singh V, Polcicova A, Barath P, et al
    N-Acetylglucosamine-1-phosphate transferase, WecA, as a validated drug target in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Sep 5. pii: AAC.01310.
    >> Share

  41. PARK SW, Tasneen R, Converse PJ, Nuermberger EL, et al
    Immunodeficiency and Intermittent Dosing Promote Acquired Rifamycin Monoresistance in Murine Tuberculosis.
    Antimicrob Agents Chemother. 2017 Sep 5. pii: AAC.01502.
    >> Share

  42. PELOQUIN CA, Velasquez GE, Lecca L, Calderon RI, et al
    Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis".
    Antimicrob Agents Chemother. 2017;61.
    >> Share

  43. ARORA K, Ochoa-Montano B, Tsang PS, Blundell TL, et al
    Correction for Arora et al., "Respiratory Flexibility in Response to Inhibition of Cytochrome c Oxidase in Mycobacterium tuberculosis".
    Antimicrob Agents Chemother. 2017;61.
    >> Share

    August 2017
  44. SHEKHOVA E, Kniemeyer O, Brakhage AA
    Induction of mitochondrial ROS production by itraconazole, terbinafine and amphotericin B as a mode of action against Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2017 Aug 28. pii: AAC.00978.
    >> Share

  45. FAKHIM H, Chowdhary A, Prakash A, Vaezi A, et al
    In Vitro Interactions of Echinocandins with Triazoles Against Multidrug-Resistant Candida auris.
    Antimicrob Agents Chemother. 2017 Aug 28. pii: AAC.01056.
    >> Share

  46. KATAYAMA Y, Azechi T, Miyazaki M, Takata T, et al
    Prevalence of Slow-growth Vancomycin Non-susceptibility In Methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Aug 21. pii: AAC.00452.
    >> Share

  47. SCHELL WA, Jones AM, Borroto-Esoda K, Alexander BD, et al
    Antifungal Activity of SCY-078 and Standard Antifungal Agents Against 178 Clinical Isolates of Resistant and Susceptible Candida Species.
    Antimicrob Agents Chemother. 2017 Aug 21. pii: AAC.01102.
    >> Share

  48. CHEUNG YY, Hui M
    Effects of Echinocandins in combination with Nikkomycin Z against invasive Candida albicans bloodstream isolates and the fks mutants.
    Antimicrob Agents Chemother. 2017 Aug 21. pii: AAC.00619.
    >> Share

  49. LIU Z, Myers LC
    Candida albicans Swi/Snf and Mediator Complexes Differentially Regulate Mrr1-induced MDR1 Expression and Fluconazole Resistance.
    Antimicrob Agents Chemother. 2017 Aug 14. pii: AAC.01344.
    >> Share

  50. LIU Z, Myers LC
    Mediator Tail Module is Required for Tac1 Activated CDR1 Expression and Azole Resistance in Candida albicans.
    Antimicrob Agents Chemother. 2017 Aug 14. pii: AAC.01342.
    >> Share

  51. MOJICA SA, Salin O, Bastidas RJ, Sunduru N, et al
    N-acylated derivatives of sulfamethoxazole block Chlamydia fatty acid synthesis and interact with FabF.
    Antimicrob Agents Chemother. 2017 Aug 7. pii: AAC.00716.
    >> Share

  52. RENZONI A, Von Dach E, Landelle C, Diene SM, et al
    Impact of exposure of methicillin-resistant Staphylococcus aureus to polyhexanide in vitro and in vivo.
    Antimicrob Agents Chemother. 2017 Aug 7. pii: AAC.00272.
    >> Share

  53. BELLEY A, Lalonde-Seguin D, Arhin FF, Moeck G, et al
    Comparative Pharmacodynamics of Single-Dose Oritavancin and Daily High-Dose Daptomycin Regimens against Vancomycin-resistant Enterococcus faecium Isolates in an In Vitro PK/PD Model of Infection.
    Antimicrob Agents Chemother. 2017 Aug 7. pii: AAC.01265.
    >> Share

  54. CASTANHEIRA M, Deshpande LM, Davis AP, Rhomberg PR, et al
    Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Moulds: Application of CLSI Epidemiological Cutoff Values and Whole Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Antimicrob Agents Chemother. 2017 Aug 7. pii: AAC.00906.
    >> Share

  55. ROSSLER S, Bader O, Stolzel F, Sommer U, et al
    Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a cyp51A TR46 Y121F M172I T289A Allele.
    Antimicrob Agents Chemother. 2017;61.
    >> Share

    July 2017
  56. MORENO-VELASQUEZ SD, Seidel C, Juvvadi PR, Steinbach WJ, et al
    Caspofungin-Mediated Growth Inhibition and Paradoxical Growth in Aspergillus fumigatus involve Fungicidal Hyphal Tip Lysis Coupled with Regenerative Intrahyphal Growth and Dynamic Changes in beta-1,3-Glucan Synthase Localization.
    Antimicrob Agents Chemother. 2017 Jul 31. pii: AAC.00710.
    >> Share

  57. MOOSA A, Lamprecht DA, Arora K, Barry CE 3rd, et al
    Susceptibility of Mycobacterium tuberculosis cytochrome bd oxidase mutants to compounds targeting the terminal respiratory oxidase, cytochrome c.
    Antimicrob Agents Chemother. 2017 Jul 31. pii: AAC.01338.
    >> Share

  58. ARIAS CA, Reyes J, Carvajal LP, Rincon S, et al
    Molecular Epidemiology and Phylogenomics of Staphylococcus aureus Bacteremia in Latin-America: A Prospective Cohort Multicenter Study in Nine Countries.
    Antimicrob Agents Chemother. 2017 Jul 31. pii: AAC.00816.
    >> Share

  59. MCMANUS BA, O'Connor AM, Kinnevey PM, O'Sullivan M, et al
    First Detailed Genetic Characterization of the Structural Organization of Type III Arginine Catabolic Mobile Elements (ACMEs) Harbored by Staphylococcus epidermidis using Whole Genome Sequencing.
    Antimicrob Agents Chemother. 2017 Jul 31. pii: AAC.01216.
    >> Share

  60. MCNEIL MB, Dennison D, Shelton C, Parish T, et al
    In vitro isolation and characterization of oxazolidinone resistant Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Jul 31. pii: AAC.01296.
    >> Share

  61. ALSULTAN A, Furin JJ, Du Bois J, van Brakel E, et al
    Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis.
    Antimicrob Agents Chemother. 2017 Jul 24. pii: AAC.01066.
    >> Share

  62. JUKIC E, Blatzer M, Posch W, Steger M, et al
    Oxidative stress response tips the balance in Aspergillus terreus AmB resistance.
    Antimicrob Agents Chemother. 2017 Jul 24. pii: AAC.00670.
    >> Share

  63. MOURIK BC, de Knegt GJ, Verbon A, Mouton JW, et al
    Assessment of bactericidal drug activity and treatment outcome in a mouse tuberculosis model using a clinical Beijing strain.
    Antimicrob Agents Chemother. 2017 Jul 24. pii: AAC.00696.
    >> Share

  64. PANG Y, Zong Z, Huo F, Jing W, et al
    In vitro drug susceptibility of bedaquiline, delamanid, linezolid, clofazimine, moxifloxacin, and gatifloxacin against extensively drug -resistant tuberculosis from Beijing, China.
    Antimicrob Agents Chemother. 2017 Jul 24. pii: AAC.00900.
    >> Share

  65. YANG SS, Hu YB, Wang XD, Gao YR, et al
    Deletion of sigB Causes Increased Sensitivity to para-Aminosalicylic Acid and Sulfamethoxazole in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Jul 17. pii: AAC.00551.
    >> Share

  66. XIONG YQ, Estelles A, Li L, Abdelhady W, et al
    A Human Biofilm-Disrupting Monoclonal Antibody Potentiates Antibiotic Efficacy in Rodent Models of both Staphylococcus aureus and Acinetobacter baumannii Infections.
    Antimicrob Agents Chemother. 2017 Jul 17. pii: AAC.00904.
    >> Share

  67. ZIMMERMAN M, Lestner J, Prideaux B, O'Brien P, et al
    Ethambutol partitioning in tuberculous pulmonary lesions explains its clinical efficacy.
    Antimicrob Agents Chemother. 2017 Jul 10. pii: AAC.00924.
    >> Share

  68. VAN RIJN SP, Srivastava S, Wessels MA, van Soolingen D, et al
    The sterilizing effect of ertapenem-clavulanate in a hollow fiber model of tuberculosis and implications on clinical dosing.
    Antimicrob Agents Chemother. 2017 Jul 10. pii: AAC.02039.
    >> Share

  69. PETRAITIS V, Petraitiene R, McCarthy MW, Kovanda LL, et al
    Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis.
    Antimicrob Agents Chemother. 2017 Jul 10. pii: AAC.00305.
    >> Share

  70. PATEL N, O'Malley T, Zhang YK, Xia Y, et al
    A novel 6-benzyl ether benzoxaborole is active against Mycobacterium tuberculosis in vitro.
    Antimicrob Agents Chemother. 2017 Jul 3. pii: AAC.01205.
    >> Share

  71. LONG TE
    Repurposing thiram and disulfiram as antibacterial agents for multi-drug resistant Staphylococcus aureus infections.
    Antimicrob Agents Chemother. 2017 Jul 3. pii: AAC.00898.
    >> Share

    June 2017
  72. BABLISHVILI N, Tukvadze N, Shashkina E, Mathema B, et al
    The impact of gyrB and eis mutations in improving second-line drug resistance detection among Mycobacterium tuberculosis isolates from Georgia.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.01921.
    >> Share

  73. LI SY, Tasneen R, Tyagi S, Soni H, et al
    Bactericidal and sterilizing activity of a novel regimen with bedaquiline, pretomanid, moxifloxacin and pyrazinamide in a murine model of tuberculosis.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.00913.
    >> Share

  74. CHIBA N, Murayama SY, Morozumi M, Iwata S, et al
    Genome Evolution to Penicillin Resistance in Serotype 3 Streptococcus pneumoniae by Capsular Switching.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.00478.
    >> Share

  75. SADER HS, Mendes RE, Streit JM, Flamm RK, et al
    Antimicrobial Susceptibility Trends Among Staphylococcus aureus from United States Hospitals: Results from 7 Years of the Ceftaroline (AWARE) Surveillance Program (2010-2016).
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.01043.
    >> Share

  76. SANMIGUEL AJ, Meisel JS, Horwinski J, Zheng Q, et al
    Topical antimicrobial treatments can elicit shifts to resident skin bacterial communities and reduce colonization by Staphylococcus aureus competitors.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.00774.
    >> Share

  77. RAHMAN A, Ferdous SS, Ahmed S, Rahman SMM, et al
    Pyrazinamide susceptibility and pncA mutation profile of Mycobacterium tuberculosis among multi-drug resistant tuberculosis patients in Bangladesh.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.00511.
    >> Share

  78. FERRER-GONZALEZ E, Kaul M, Parhi AK, LaVoie EJ, et al
    beta-Lactam Antibiotics with a High Affinity for PBP2 Act Synergistically with the FtsZ-Targeting Agent TXA707 against Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.00863.
    >> Share

  79. RYBAK JM, Dickens CM, Parker JE, Caudle K, et al
    Loss of C-5 sterol desaturase activity results in increased resistance to azole and echinocandin antifungals in a clinical isolate of Candida parapsilosis.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.00651.
    >> Share

  80. KIMURA G, Nakaoki T, Colley T, Rapeport G, et al
    In vivo biomarker analysis of intranasally dosed PC945, a novel antifungal triazole, on Aspergillus fumigatus infection in immunocompromised mice.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.00124.
    >> Share

  81. JIMENEZ-ORTIGOSA C, Perez WB, Angulo D, Borroto-Esoda K, et al
    De novo acquisition of resistance to SCY-078 in Candida glabrata involves FKS mutations that both overlap and are distinct from those conferring echinocandin resistance.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.00833.
    >> Share

  82. MALHOTRA S, Singh S, Rana N, Tomar S, et al
    Chemoenzymatic synthesis, nanotization and anti-Aspergillus activity of optically enriched fluconazole analogues.
    Antimicrob Agents Chemother. 2017 Jun 12. pii: AAC.00273.
    >> Share

  83. CHIREHWA MT, McIlleron H, Rustomjee R, Mthiyane T, et al
    Pharmacokinetics of Pyrazinamide: optimising dosing regimens for drug-sensitive and -resistant tuberculosis.
    Antimicrob Agents Chemother. 2017 Jun 12. pii: AAC.00490.
    >> Share

  84. RODRIGUES FELIX C, Gupta R, Geden S, Roberts J, et al
    Selective Killing Of Dormant Mycobacterium tuberculosis By Marine Natural Products.
    Antimicrob Agents Chemother. 2017 Jun 12. pii: AAC.00743.
    >> Share

  85. HASHIMOTO A, Hagiwara D, Watanabe A, Yahiro M, et al
    Drug sensitivity and resistance mechanism in Aspergillus section Nigri strains from Japan.
    Antimicrob Agents Chemother. 2017 Jun 12. pii: AAC.02583.
    >> Share

  86. MERCER DK, Katvars LK, Hewitt F, Smith DW, et al
    NP108, an antimicrobial polymer with activity against methicillin and mupirocin resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Jun 12. pii: AAC.00502.
    >> Share

  87. LI DD, Chai D, Huang XW, Guan SX, et al
    Potent In Vitro Synergism of Fluconazole and Osthole against Fluconazole-Resistant Candida albicans.
    Antimicrob Agents Chemother. 2017 Jun 12. pii: AAC.00436.
    >> Share

  88. LIU RH, Shang ZC, Li TX, Yang MH, et al
    In vitro Antibiofilm Activity of Eucarobustol E against Candida albicans.
    Antimicrob Agents Chemother. 2017 Jun 5. pii: AAC.02707.
    >> Share

  89. ZHANG Y, Zhang J, Cui P, Zhang W, et al
    Identification of novel efflux proteins Rv0191, Rv3756c, Rv3008 and Rv1667c involved in pyrazinamide resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Jun 5. pii: AAC.00940.
    >> Share

  90. LEPAK AJ, Zhao M, Berkow EL, Lockhart SR, et al
    Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.
    Antimicrob Agents Chemother. 2017 Jun 5. pii: AAC.00791.
    >> Share

  91. TRUONG-BOLDUC QC, Wang Y, Chen C, Hooper DC, et al
    Transcriptional Regulator TetR21 Controls the Expression of Staphylococcus aureus LmrS Efflux Pump.
    Antimicrob Agents Chemother. 2017 Jun 5. pii: AAC.00649.
    >> Share

  92. KLEINERT F, Kallies R, Hort M, Zweynert A, et al
    Influence of IS256 on genome variability and formation of SCV in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Jun 5. pii: AAC.00144.
    >> Share

  93. SRIVASTAVA S, Magombedze G, Koeuth T, Sherman C, et al
    Linezolid dose that maximizes sterilizing effect while minimizing toxicity and resistance emergence for tuberculosis.
    Antimicrob Agents Chemother. 2017 Jun 5. pii: AAC.00751.
    >> Share

  94. LE A, Farmakiotis D, Tarrand JJ, Kontoyiannis DP, et al
    Initial treatment of cancer patients with fluconazole susceptible dose-dependent Candida glabrata fungemia: Better outcome with an echinocandin or polyene compared to an azole?
    Antimicrob Agents Chemother. 2017 Jun 5. pii: AAC.00631.
    >> Share

  95. FOFANA MO, Dowdy DW
    Reply to Anthony et al., "Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment".
    Antimicrob Agents Chemother. 2017;61.
    >> Share

  96. ANTHONY RM, Cynamon M, Hoffner S, Werngren J, et al
    Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment.
    Antimicrob Agents Chemother. 2017;61.
    >> Share

    May 2017
  97. PELOQUIN CA, Velasquez GE, Lecca L, Calderon RI, et al
    Pharmacokinetic evidence to support increased doses of rifampin for tuberculosis: results from the HIRIF trial.
    Antimicrob Agents Chemother. 2017 May 30. pii: AAC.00038.
    >> Share

  98. POONACHA N, Nair S, Desai S, Tuppad D, et al
    Efficient Killing of Planktonic and Biofilm Embedded Coagulase-Negative Staphylococci by Bactericidal Protein P128.
    Antimicrob Agents Chemother. 2017 May 30. pii: AAC.00457.
    >> Share

  99. AIGNER M, Erbeznik T, Gschwentner M, Lass-Florl C, et al
    Susceptibility testing of the echinocandins against Candida species in the daily routine: ETest(R) versus Sensititre YeastOne(R). Data from a single center in Austria.
    Antimicrob Agents Chemother. 2017 May 30. pii: AAC.00512.
    >> Share

  100. WULKERSDORFER B, Jaros D, Eberl S, Poschner S, et al
    Human Bile Reduces Antimicrobial Activity of Selected Antibiotics Against Enterococcus faecalis and Escherichia coli in vitro.
    Antimicrob Agents Chemother. 2017 May 30. pii: AAC.00527.
    >> Share

  101. MIN KR, Galvis A, Williams B, Rayala R, et al
    Antibacterial and Antibiofilm Activities of a Novel Synthetic Cyclic Lipopeptide Against Cariogenic Streptococcus mutans UA159.
    Antimicrob Agents Chemother. 2017 May 22. pii: AAC.00776.
    >> Share

  102. PFALLER MA, Messer SA, Rhomberg PR, Castanheira M, et al
    Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida spp.
    Antimicrob Agents Chemother. 2017 May 22. pii: AAC.00161.
    >> Share

  103. VAN'T BOVENEIND-VRUBLEUSKAYA N, Seuruk T, van Hateren K, van der Laan T, et al
    Pharmacokinetics of Levofloxacin in Multidrug- and Extensively Drug-Resistant Tuberculosis patients.
    Antimicrob Agents Chemother. 2017 May 15. pii: AAC.00343.
    >> Share

  104. CRAIK VB, Johnson AD, Lohse MB
    Sensitivity of White and Opaque Candida albicans to Antifungal Drugs.
    Antimicrob Agents Chemother. 2017 May 15. pii: AAC.00166.
    >> Share

  105. KLEIN K, Gronnemose RB, Alm M, Brinch KS, et al
    Controlled release of plectasin NZ2114 from a hybrid silicone-hydrogel material for inhibition of Staphylococcus aureus biofilm.
    Antimicrob Agents Chemother. 2017 May 15. pii: AAC.00604.
    >> Share

  106. YOU L, Qian W, Yang Q, Mao L, et al
    ERG11 gene mutations and MDR1 up-regulation confer pan-azole-resistance in Candida tropicalis causing disseminated candidiasis while on posaconazole prophylaxis in an acute lymphoblastic leukemia patient.
    Antimicrob Agents Chemother. 2017 May 15. pii: AAC.02496.
    >> Share

  107. SULLIVAN SB, Austin ED, Stump S, Mathema B, et al
    Reduced vancomycin susceptibility of methicillin-susceptible Staphylococcus aureus: no significant impact on mortality but increase in complicated infection.
    Antimicrob Agents Chemother. 2017 May 15. pii: AAC.00316.
    >> Share

  108. ALVES IA, Staudt KJ, de Miranda Silva C, de Araujo Lock G, et al
    Influence of Experimental Cryptococcal Meningitis in Wistar Rats on Voriconazole Brain Penetration Assessed by Microdialysis.
    Antimicrob Agents Chemother. 2017 May 8. pii: AAC.00321.
    >> Share

  109. SINGH KV, Tran TT, Nannini EC, Tam VH, et al
    Efficacy of Ceftaroline in a Rat Model of Endocarditis Against Methicillin-Susceptible Staphylococcus aureus Exhibiting the Cefazolin High Inoculum Effect.
    Antimicrob Agents Chemother. 2017 May 8. pii: AAC.00324.
    >> Share

  110. SCHWEIZER I, Blattner S, Maurer P, Peters K, et al
    New aspects of the interplay between penicillin binding proteins, murM and the two component system CiaRH of penicillin-resistant Streptococcus pneumoniae serotype 19A isolates from Hungary.
    Antimicrob Agents Chemother. 2017 May 8. pii: AAC.00414.
    >> Share

  111. CATTANA ME, Dudiuk C, Fernandez M, Rojas F, et al
    Candida parapsilosis sensu lato in pediatric patients. Identification of cryptic species and antifungal susceptibility testing.
    Antimicrob Agents Chemother. 2017 May 8. pii: AAC.02754.
    >> Share

  112. BERKOW EL, Angulo D, Lockhart SR
    In Vitro activity of a novel glucan synthase inhibitor, SCY-078, against clinical isolates of Candida auris.
    Antimicrob Agents Chemother. 2017 May 8. pii: AAC.00435.
    >> Share

  113. ESCRIBANO P, Marcos-Zambrano LJ, Gomez A, Sanchez C, et al
    The Etest performed directly on blood culture bottles is a reliable tool for detection of fluconazole-resistant Candida albicans isolates.
    Antimicrob Agents Chemother. 2017 May 8. pii: AAC.00400.
    >> Share

  114. SCHUCH R, Khan BK, Raz A, Rotolo JA, et al
    Bacteriophage Lysin CF-301: a Potent Anti-Staphylococcal Biofilm Agent.
    Antimicrob Agents Chemother. 2017 May 1. pii: AAC.02666.
    >> Share

  115. POPP C, Hampe I, Hertlein T, Ohlsen K, et al
    Competitive fitness of fluconazole-resistant, clinical Candida albicans strains.
    Antimicrob Agents Chemother. 2017 May 1. pii: AAC.00584.
    >> Share

  116. SLOAN DJ, McCallum AD, Schipani A, Egan D, et al
    Genetic determinants of the pharmacokinetic variability of rifampicin in Malawian adults with pulmonary tuberculosis.
    Antimicrob Agents Chemother. 2017 May 1. pii: AAC.00210.
    >> Share

  117. MORALES-LOPEZ S, Dudiuk C, Vivot W, Szusz W, et al
    Phenotypic and molecular evaluation of echinocandin susceptibility of Candida glabrata, Candida bracarensis and Candida nivariensis strains isolated during 30 years in Argentina.
    Antimicrob Agents Chemother. 2017 May 1. pii: AAC.00170.
    >> Share

  118. HARGROVE TY, Garvey EP, Hoekstra WJ, Yates CM, et al
    Crystal structure of the new investigational drug candidate VT-1598 in complex with Aspergillus fumigatus sterol 14alpha-demethylase provides insights into its broad-spectrum antifungal activity.
    Antimicrob Agents Chemother. 2017 May 1. pii: AAC.00570.
    >> Share

    April 2017
  119. WIPF JRK, Riley MC, Kania SA, Bemis DA, et al
    New macrolide-lincosamide-streptogramin B resistance gene erm(48) on the novel plasmid pJW2311 in Staphylococcus xylosus.
    Antimicrob Agents Chemother. 2017 Apr 24. pii: AAC.00066.
    >> Share

  120. ABRAHAM NM, Liu L, Jutras BL, Murfin K, et al
    A tick antivirulence protein potentiates antibiotics against Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Apr 24. pii: AAC.00113.
    >> Share

  121. MARCOS-ZAMBRANO LJ, Puig-Asensio M, Perez-Garcia F, Escribano P, et al
    Candida guilliermondii complex is characterized by high antifungal resistance but low mortality: a report on 22 cases of candidemia.
    Antimicrob Agents Chemother. 2017 Apr 24. pii: AAC.00099.
    >> Share

  122. NJIRE M, Wang N, Wang B, Tan Y, et al
    Pyrazinoic Acid Inhibits a Bifunctional Enzyme in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Apr 24. pii: AAC.00070.
    >> Share

  123. MCNEIL JC, Hulten KG, Mason EO, Kaplan SL, et al
    The impact of healthcare exposure on genotypic antiseptic tolerance among pediatric Staphylococcus aureus infections.
    Antimicrob Agents Chemother. 2017 Apr 24. pii: AAC.00223.
    >> Share

  124. VISWANATHAN G, Yadav S, Raghunand TR
    Identification of mycobacterial genes involved in antibiotic sensitivity - Implications in the treatment of tuberculosis with beta-lactam containing regimens.
    Antimicrob Agents Chemother. 2017 Apr 24. pii: AAC.00425.
    >> Share

  125. OLLIARO PL, Merle C, Mthiyane T, Bah B, et al
    Analysis of the effects on the QT interval of a gatifloxacin-containing regimen versus standard treatment of pulmonary tuberculosis.
    Antimicrob Agents Chemother. 2017 Apr 24. pii: AAC.01834.
    >> Share

  126. DANELISHVILI L, Shulzhenko N, Chinison JJJ, Babrak L, et al
    Mycobacterium tuberculosis proteome response to anti-tuberculosis compounds reveals metabolic "escape" pathways that prolong bacterial survival.
    Antimicrob Agents Chemother. 2017 Apr 17. pii: AAC.00430.
    >> Share

  127. LEPAK AJ, Zhao M, Andes DR
    Comparative Pharmacodynamics of Telavancin and Vancomycin in the Neutropenic Murine Thigh and Lung Infection Models against Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Apr 17. pii: AAC.00281.
    >> Share

  128. JANG J, Kim R, Woo M, Jeong J, et al
    Efflux attenuates the anti-bacterial activity of Q203 in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Apr 17. pii: AAC.02637.
    >> Share

  129. SEYEDMOUSAVI S, Mouton JW, Melchers WJG, Verweij PE, et al
    In vivo efficacy of liposomal amphotericin B against wild type and azole-resistant Aspergillus fumigatus isolates in two different immunosuppressed models of invasive aspergillosis.
    Antimicrob Agents Chemother. 2017 Apr 17. pii: AAC.02479.
    >> Share

  130. ARENDRUP MC, Prakash A, Meletiadis J, Sharma C, et al
    Candida auris: Comparison of the EUCAST and CLSI reference microdilution MICs for eight antifungal compounds and associated tentative ECOFFs.
    Antimicrob Agents Chemother. 2017 Apr 17. pii: AAC.00485.
    >> Share

  131. MELLO E, Posteraro B, Vella A, De Carolis E, et al
    Susceptibility Testing of Common and Uncommon Aspergillus Species Against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method.
    Antimicrob Agents Chemother. 2017 Apr 17. pii: AAC.00168.
    >> Share

  132. ROLO J, Worning P, Nielsen JB, Bowden R, et al
    Evolutionary origin of the staphylococcal cassette chromosome mec (SCCmec).
    Antimicrob Agents Chemother. 2017 Apr 3. pii: AAC.02302.
    >> Share

  133. KEMPKER RR, Heinrichs MT, Nikolaishvili K, Sabulua I, et al
    Lung Tissue Concentrations of Pyrazinamide among Patients with Drug-Resistant Pulmonary Tuberculosis.
    Antimicrob Agents Chemother. 2017 Apr 3. pii: AAC.00226.
    >> Share

  134. HAMILTON SM, Alexander JA, Choo EJ, Basuino L, et al
    High-Level Resistance of Staphylococcus aureus to beta-Lactam Antibiotics Mediated by Penicillin-Binding Protein 4 (PBP4).
    Antimicrob Agents Chemother. 2017 Apr 3. pii: AAC.02727.
    >> Share

  135. CHEN X, Hashizume H, Tomishige T, Nakamura I, et al
    Delamanid Kills Dormant Mycobacteria in Vitro and in the Guinea Pig Model of Tuberculosis.
    Antimicrob Agents Chemother. 2017 Apr 3. pii: AAC.02402.
    >> Share

  136. CASTANEDA X, Garcia-de-la-Maria C, Gasch O, Pericas JM, et al
    AUC/MIC pharmacodynamic target is not a good predictor of vancomycin efficacy in methicillin-resistant Staphylococcus aureus (MRSA) experimental endocarditis.
    Antimicrob Agents Chemother. 2017 Apr 3. pii: AAC.02486.
    >> Share

    March 2017
  137. PETERS BM, Luna-Tapia A, Tournu H, Rybak JM, et al
    An azole tolerant endosomal trafficking mutant of Candida albicans is susceptible to azole treatment in a mouse model of vaginal candidiasis.
    Antimicrob Agents Chemother. 2017 Mar 27. pii: AAC.00084.
    >> Share

  138. XU J, Wang B, Hu M, Huo F, et al
    Primary clofazimine and bedaquiline resistance among isolates from patients with multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2017 Mar 20. pii: AAC.00239.
    >> Share

  139. VEMULA H, Ayon NJ, Burton A, Gutheil WG, et al
    Antibiotic Effects on Methicillin Resistant Staphylococcus aureus Cytoplasmic Peptidoglycan Intermediate Levels; Evidence for Potential Metabolite Level Regulatory Loops.
    Antimicrob Agents Chemother. 2017 Mar 20. pii: AAC.02253.
    >> Share

  140. LESTNER J, McEntee L, Johnson A, Livermore J, et al
    Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis.
    Antimicrob Agents Chemother. 2017 Mar 20. pii: AAC.00090.
    >> Share

  141. TRAN TT, Tam VH, Murray BE, Arias CA, et al
    Efficacy of Telavancin Alone and in Combination with Ampicillin in a Rat Model of Enterococcus faecalis Endocarditis.
    Antimicrob Agents Chemother. 2017 Mar 20. pii: AAC.02489.
    >> Share

  142. ALSULTAN A, Savic R, Dooley KE, Weiner M, et al
    Population Pharmacokinetics of Pyrazinamide in Patients with Tuberculosis.
    Antimicrob Agents Chemother. 2017 Mar 13. pii: AAC.02625.
    >> Share

  143. FERNANDEZ L, Gonzalez S, Campelo AB, Martinez B, et al
    Downregulation of autolysin-encoding genes by phage-derived lytic proteins inhibits biofilm formation in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Mar 13. pii: AAC.02724.
    >> Share

  144. LOHSE MB, Gulati M, Arevalo AV, Fishburn A, et al
    Assessment and optimizations of Candida albicans in vitro biofilm assays.
    Antimicrob Agents Chemother. 2017 Mar 13. pii: AAC.02749.
    >> Share

  145. BRITT NS, Potter EM, Patel N, Steed ME, et al
    Effect of Continuous and Sequential Therapy Among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.
    Antimicrob Agents Chemother. 2017 Mar 6. pii: AAC.02216.
    >> Share

  146. TAGHIZADEH-ARMAKI M, Hedayati MT, Ansari S, Mahdavi Omran S, et al
    Genetic diversity and in vitro antifungal susceptibility of 200 clinical and environmental Aspergillus flavus isolates.
    Antimicrob Agents Chemother. 2017 Mar 6. pii: AAC.00004.
    >> Share

  147. GARCIA-DE-LA-MARIA C, Xiong YQ, Pericas JM, Armero Y, et al
    Impact of High-Level Daptomycin-Resistance in Streptococcus mitis group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.
    Antimicrob Agents Chemother. 2017 Mar 6. pii: AAC.02418.
    >> Share

  148. PAUL S, Diekema D, Moye-Rowley WS
    Contributions of both ATP-binding cassette transporter and Cyp51A proteins are essential for azole resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2017 Mar 6. pii: AAC.02748.
    >> Share

  149. SCHILCHER K, Dengler Haunreiter V, Zinkernagel AS
    Reply to "Modulatory Effects of a Subinhibitory Concentration of Clindamycin in Community-Acquired Methicillin-Resistant Staphylococcus aureus Strains of Sequence Type 30".
    Antimicrob Agents Chemother. 2017;61.
    >> Share

  150. WONG CK, Zheng L, Ip M
    Modulatory Effects of a Subinhibitory Concentration of Clindamycin in Community-Acquired Methicillin-Resistant Staphylococcus aureus Strains of Sequence Type 30.
    Antimicrob Agents Chemother. 2017;61.
    >> Share

  151. NIGO M, Diaz L, Carvajal LP, Tran TT, et al
    Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.
    Antimicrob Agents Chemother. 2017;61.
    >> Share

  152. VELASQUEZ GE, Calderon RI, Mitnick CD, Becerra MC, et al
    Erratum for Velasquez et al., Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.
    Antimicrob Agents Chemother. 2017;61.
    >> Share

    February 2017
  153. CHAVADA R, Ghosh N, Sandaradura I, Maley M, et al
    Towards individualised vancomycin dosing in Methicillin-resistant Staphylococcus aureus bacteraemia: establishment of an AUC0-24 threshold for nephrotoxicity.
    Antimicrob Agents Chemother. 2017 Feb 27. pii: AAC.02535.
    >> Share

  154. GUZMAN PRIETO AM, Wijngaarden J, Braat JC, Rogers MR, et al
    The two component system ChtRS contributes to chlorhexidine tolerance in Enterococcus faecium.
    Antimicrob Agents Chemother. 2017 Feb 27. pii: AAC.02122.
    >> Share

  155. RAMACHANDRAN G, Kumar AK, Chandrasekaran V, Kannan T, et al
    Factors influencing tuberculosis treatment outcome in adult patients treated with thrice-weekly regimens in India.
    Antimicrob Agents Chemother. 2017 Feb 27. pii: AAC.02464.
    >> Share

  156. DUDIUK C, Macedo D, Leonardelli F, Theill L, et al
    Molecular confirmation of the relationship between Candida guilliermondii Fks1p naturally occurring amino acid substitutions and its intrinsic reduced echinocandin susceptibility.
    Antimicrob Agents Chemother. 2017 Feb 27. pii: AAC.02644.
    >> Share

  157. ADAMS HM, Joyce LR, Guan Z, Akins RL, et al
    Streptococcus mitis and S. oralis lack a requirement for CdsA, the enzyme required for synthesis of major membrane phospholipids in bacteria.
    Antimicrob Agents Chemother. 2017 Feb 21. pii: AAC.02552.
    >> Share

  158. COLLEY T, Alanio A, Kelly SL, Sehra G, et al
    In vitro and in vivo antifungal profile of a novel and long acting inhaled azole, PC945, on Aspergillus fumigatus infection.
    Antimicrob Agents Chemother. 2017 Feb 21. pii: AAC.02280.
    >> Share

  159. ZHONG H, Hu DD, Hu GH, Su J, et al
    Activity of sanguinarine against Candida albicans biofilms.
    Antimicrob Agents Chemother. 2017 Feb 21. pii: AAC.02259.
    >> Share

  160. YANG F, Zhang L, Wakabayashi H, Myers J, et al
    Tolerance to caspofungin in Candida albicans is associated with at least three distinctive mechanisms that govern expression of FKS genes and cell wall remodeling.
    Antimicrob Agents Chemother. 2017 Feb 21. pii: AAC.00071.
    >> Share

  161. KELLOGG SL, Little JL, Hoff JS, Kristich CJ, et al
    Requirement of the CroRS two-component system for resistance to cell-wall-targeting antimicrobials in Enterococcus faecium.
    Antimicrob Agents Chemother. 2017 Feb 21. pii: AAC.02461.
    >> Share

  162. LARKIN E, Hager C, Chandra J, Mukherjee PK, et al
    The Emerging Candida auris: Characterization of Growth Phenotype, Virulence Factors, Antifungal Activity, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
    Antimicrob Agents Chemother. 2017 Feb 21. pii: AAC.02396.
    >> Share

  163. SINEL C, Cacaci M, Meignen P, Guerin F, et al
    Subinhibitory concentrations of ciprofloxacin enhance antimicrobial resistance and pathogenicity of Enterococcus faecium.
    Antimicrob Agents Chemother. 2017 Feb 13. pii: AAC.02763.
    >> Share

  164. GLOUX K, Guillemet M, Soler C, Morvan C, et al
    Clinical relevance of FASII bypass in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Feb 13. pii: AAC.02515.
    >> Share

  165. LEPAK AJ, Zhao M, Marchillo K, VanHecker J, et al
    In vivo Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Streptococcus pneumoniae in the Murine Pneumonia Model.
    Antimicrob Agents Chemother. 2017 Feb 13. pii: AAC.02368.
    >> Share

  166. VAN DER LINDEN M, Otten J, Bergmann C, Latorre C, et al
    PBP2x in Streptococcus pseudopneumoniae - an insight into the diversity of PBP2x alleles and mutations in viridans streptococci.
    Antimicrob Agents Chemother. 2017 Feb 13. pii: AAC.02646.
    >> Share

  167. ABENGOZAR MA, Cebrian R, Saugar JM, Garate T, et al
    The enterocin AS-48 as an evidence for the use of bacteriocins as new leishmanicidal agents.
    Antimicrob Agents Chemother. 2017 Feb 6. pii: AAC.02288.
    >> Share

  168. KAYIGIRE XA, Friedrich SO, van der Merwe L, Diacon AH, et al
    Acquisition of rifampin resistance in pulmonary tuberculosis.
    Antimicrob Agents Chemother. 2017 Feb 6. pii: AAC.02220.
    >> Share

    January 2017
  169. LE VT, Le HN, Pinheiro MG, Hahn KJ, et al
    Effects of tedizolid phosphate on survival outcomes and suppression of production of staphylococcal toxins in a rabbit model of MRSA necrotizing pneumonia.
    Antimicrob Agents Chemother. 2017 Jan 30. pii: AAC.02734.
    >> Share

  170. AJILEYE A, Alvarez N, Merker M, Walker TM, et al
    Some synonymous and non-synonymous gyrA mutations in Mycobacterium tuberculosis lead to systematic false-resistance results to fluoroquinolones with the Hain GenoType MTBDRsl assays.
    Antimicrob Agents Chemother. 2017 Jan 30. pii: AAC.02169.
    >> Share

  171. DE JAGER V, van der Merwe L, Venter A, Donald PR, et al
    Time trends in sputum mycobacterial load and 2-day bactericidal activity of INH-containing anti-tuberculosis therapies.
    Antimicrob Agents Chemother. 2017 Jan 30. pii: AAC.02088.
    >> Share

  172. GELDART K, Kaznessis YN
    Characterization of Class IIa Bacteriocin Resistance in Enterococcus faecium.
    Antimicrob Agents Chemother. 2017 Jan 23. pii: AAC.02033.
    >> Share

  173. MELETIADIS J, Curfs-Breuker I, Meis JF, Mouton JW, et al
    In vitro antifungal susceptibility testing of Candida isolates with the EUCAST methodology.
    Antimicrob Agents Chemother. 2017 Jan 23. pii: AAC.02372.
    >> Share

  174. MISHRA NN, Tran TT, Seepersaud R, Garcia-de-la-Maria C, et al
    Perturbations of Phosphatidate Cytidylyltransferase (CdsA) Mediate Daptomycin Resistance in Streptococcus mitis by a Novel Mechanism.
    Antimicrob Agents Chemother. 2017 Jan 23. pii: AAC.02435.
    >> Share

  175. DIEP BA, Hillard JJ, Le VT, Tkaczyk C, et al
    Targeting Alpha Toxin to Mitigate Its Lethal Toxicity in Ferret and Rabbit Models of Staphylococcus aureus Necrotizing Pneumonia.
    Antimicrob Agents Chemother. 2017 Jan 23. pii: AAC.02456.
    >> Share

  176. HE Y, Zhou L, Gao C, Han L, et al
    Rifampin Enhances the Activity of Amphotericin B for Fusarium solani species complex and Aspergillus flavus species complex Isolated from Keratitis.
    Antimicrob Agents Chemother. 2017 Jan 23. pii: AAC.02069.
    >> Share

  177. WERTH BJ, Shireman LM
    Pharmacodynamics of Ceftaroline Plus Ampicillin Against Enterococcus faecalis in an in vitro Pharmacokinetic/Pharmacodynamic Model of Simulated Endocardial Vegetations.
    Antimicrob Agents Chemother. 2017 Jan 17. pii: AAC.02235.
    >> Share

  178. SCORNEAUX B, Angulo D, Borroto-Esoda K, Ghannoum M, et al
    SCY-078 is Fungicidal in Time-Kill Studies Against Candida Species.
    Antimicrob Agents Chemother. 2017 Jan 9. pii: AAC.01961.
    >> Share

  179. KUMAR P, Kaushik A, Bell D, Chauhan V, et al
    Mutation in an unannotated protein confers carbapenem resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Jan 9. pii: AAC.02234.
    >> Share

  180. VAN ALTENA R, Dijkstra JA, van der Meer ME, Borjas Howard JF, et al
    Reduced chance of hearing loss associated with Therapeutic Drug Monitoring of Aminoglycosides in the treatment of Multidrug Resistant Tuberculosis.
    Antimicrob Agents Chemother. 2017 Jan 9. pii: AAC.01400.
    >> Share

  181. CAFFREY AR, Timbrook TT, Noh E, Sakoulas G, et al
    Evidence to support continuation of statin therapy in patients with Staphylococcus aureus bacteremia.
    Antimicrob Agents Chemother. 2017 Jan 9. pii: AAC.02228.
    >> Share

  182. WANG X, Davlieva M, Reyes J, Panesso D, et al
    A Novel Phosphodiesterase of the GdpP Family Modulates Cyclic di-AMP Levels in Response to Cell Membrane Stress in Daptomycin-Resistant Enterococci.
    Antimicrob Agents Chemother. 2017 Jan 9. pii: AAC.01422.
    >> Share

  183. SCHUMP MD, Fox DM, Bertozzi CR, Riley LW, et al
    Subcellular Partitioning and Intra-Macrophage Selectivity of Antimicrobial Compounds Against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Jan 4. pii: AAC.01639.
    >> Share

    December 2016
  184. PFALLER MA, Rhomberg PR, Huband MD, Flamm RK, et al
    Activity of Omadacycline and Comparator Agents When Tested against Staphylococcus aureus from a Surveillance Program Conducted in North America and Europe.
    Antimicrob Agents Chemother. 2016 Dec 19. pii: AAC.02411.
    >> Share

  185. IACOBINO A, Piccaro G, Giannoni F, Mustazzolu A, et al
    Mycobacterium tuberculosis is selectively killed by rifampin and rifapentine in hypoxia at neutral pH.
    Antimicrob Agents Chemother. 2016 Dec 19. pii: AAC.02296.
    >> Share

  186. SONG KH, Kim M, Kim CJ, Cho JE, et al
    Impact of Vancomycin Minimum Inhibitory Concentration on Treatment Outcomes in Invasive Staphylococcus aureus Infections.
    Antimicrob Agents Chemother. 2016 Dec 12. pii: AAC.01845.
    >> Share

  187. FOFANA MO, Shrestha S, Knight GM, Cohen T, et al
    Role of pyrazinamide in the emergence of extensively drug-resistant tuberculosis: a multi-strain mathematical model.
    Antimicrob Agents Chemother. 2016 Dec 12. pii: AAC.00498.
    >> Share

  188. SCHELL WA, Jones AM, Garvey EP, Hoekstra WJ, et al
    Fungal CYP51 Inhibitors VT-1161 and VT-1129 exhibit strong in vitro activity against Candida glabrata and C. krusei isolates clinically resistant to azole and echinocandin antifungal compounds.
    Antimicrob Agents Chemother. 2016 Dec 12. pii: AAC.01817.
    >> Share

  189. DOMENECH M, Garcia E
    N-Acetyl-L-cysteine and Cysteamine: New Strategies Against Mixed Biofilms of Non-encapsulated Streptococcus pneumoniae and Non-typeable Haemophilus influenzae.
    Antimicrob Agents Chemother. 2016 Dec 5. pii: AAC.01992.
    >> Share

  190. ZHANG L, Sun L, Wei R, Gao Q, et al
    Study of intracellular Staphylococcus aureus control by virulent bacteriophage within MAC-T bovine mammary epithelial cells.
    Antimicrob Agents Chemother. 2016 Dec 5. pii: AAC.01990.
    >> Share

  191. PANG Y, Zhang Z, Wang Y, Wang S, et al
    Genotyping and prevalence of pyrazinamide- and moxifloxacin-resistant tuberculosis in China, 2000-2010: findings from the national survey data.
    Antimicrob Agents Chemother. 2016 Dec 5. pii: AAC.02170.
    >> Share

    November 2016
  192. BROSSIER F, Pham A, Bernard C, Aubry A, et al
    Molecular investigation of resistance to second line injectable drugs in multidrug-resistant clinical isolates of Mycobacterium tuberculosis in France.
    Antimicrob Agents Chemother. 2016 Nov 28. pii: AAC.01299.
    >> Share

  193. ZASOWSKI EJ, Trinh TD, Claeys KC, Casapao AM, et al
    A Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Antimicrob Agents Chemother. 2016 Nov 28. pii: AAC.02015.
    >> Share

  194. SEBASTIAN J, Swaminath S, Nair RR, Jakkala K, et al
    De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells formed against Antituberculosis Drugs In Vitro.
    Antimicrob Agents Chemother. 2016 Nov 28. pii: AAC.01343.
    >> Share

  195. SAKOULAS G, Rose W, Berti A, Olson J, et al
    Classical beta-lactamase Inhibitors Potentiate the Activity of Daptomycin against Methicillin-Resistant Staphylococcus aureus and Colistin Against Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2016 Nov 21. pii: AAC.01745.
    >> Share

  196. LOIKO V, Wagener J
    The paradoxical effect of echinocandins in Aspergillus fumigatus relies on recovery of the beta-1,3-glucan synthase Fks1.
    Antimicrob Agents Chemother. 2016 Nov 21. pii: AAC.01690.
    >> Share

  197. YEE M, Gopal P, Dick T
    Missense mutations in the unfoldase ClpC1 of the caseinolytic protease complex are associated with pyrazinamide resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2016 Nov 21. pii: AAC.02342.
    >> Share

  198. ABDELHADY W, Bayer AS, Gonzales R, Li L, et al
    Telavancin (TLV) is Active Against Experimental Aortic Valve Endocarditis Caused by Daptomycin-Resistant (DAP-R) Methicillin-Resistant Staphylococcus aureus (MRSA) Strains.
    Antimicrob Agents Chemother. 2016 Nov 21. pii: AAC.01877.
    >> Share

  199. BORDALLO-CARDONA MA, Escribano P, Gomez G de la Pedrosa E, Marcos-Zambrano LJ, et al
    In vitro exposure to increasing micafungin concentrations easily promotes echinocandin resistance in Candida glabrata isolates.
    Antimicrob Agents Chemother. 2016 Nov 21. pii: AAC.01542.
    >> Share

  200. PRIGENT G, Ait-Ammar N, Levesque E, Fekkar A, et al
    Echinocandin resistance in Candida spp. isolated from liver transplant recipients.
    Antimicrob Agents Chemother. 2016 Nov 14. pii: AAC.01229.
    >> Share

  201. ROSEN BC, Dillon NA, Peterson ND, Minato Y, et al
    Long-Chain Fatty Acyl-CoA Ligase FadD2 Mediates Intrinsic Pyrazinamide Resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2016 Nov 14. pii: AAC.02130.
    >> Share

  202. ANTWI S, Yang H, Enimil A, Sarfo AM, et al
    Pharmacokinetics of the First-line Antituberculosis Drugs in Ghanaian Children with Tuberculosis with and without HIV Coinfection.
    Antimicrob Agents Chemother. 2016 Nov 14. pii: AAC.01701.
    >> Share

  203. PARK KH, Greenwood-Quaintance KE, Schuetz AN, Mandrekar JN, et al
    Activity of Tedizolid in Methicillin-Resistant Staphylococcus epidermidis Experimental Foreign Body-Associated Osteomyelitis.
    Antimicrob Agents Chemother. 2016 Nov 14. pii: AAC.01644.
    >> Share

  204. SINGH M, Matsuo M, Sasaki T, Morimoto Y, et al
    In Vitro Tolerance of A Drug-Naive Staphylococcus aureus FDA209P towards Vancomycin.
    Antimicrob Agents Chemother. 2016 Nov 14. pii: AAC.01154.
    >> Share

  205. MIHU MR, Cabral V, Pattabhi R, Tar MT, et al
    Sustained nitric oxide-releasing nanoparticles interfere with methicillin-resistant Staphylococcus aureus adhesion and biofilm formation in a rat central venous catheter model.
    Antimicrob Agents Chemother. 2016 Nov 7. pii: AAC.02020.
    >> Share

  206. RUDRAMURTHY SM, Seyedmousavi S, Dhaliwal M, Chakrabarti A, et al
    Pharmacodynamics of voriconazole against wild-type and azole-resistant Aspergillus flavus isolates in a non-neutropenic murine model of disseminated aspergillosis.
    Antimicrob Agents Chemother. 2016 Nov 7. pii: AAC.01491.
    >> Share

  207. MONTEALEGRE MC, Roh JH, Rae M, Davlieva MG, et al
    Differential Penicillin-Binding Protein 5 (PBP5) Levels in the Enterococcus faecium Clades with Different Levels of Ampicillin Resistance.
    Antimicrob Agents Chemother. 2016 Nov 7. pii: AAC.02034.
    >> Share

  208. REIS DE SA LF, Toledo FT, Goncalves AC, Sousa BA, et al
    Synthetic organotellurium compounds sensitize drug resistant Candida albicans clinical isolates to fluconazole.
    Antimicrob Agents Chemother. 2016 Nov 7. pii: AAC.01231.
    >> Share

  209. HENSON KE, Yim J, Smith JR, Sakoulas G, et al
    Beta-lactamase inhibitors enhance the synergy between beta-lactam antibiotics and daptomycin against methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2016 Nov 7. pii: AAC.01564.
    >> Share

  210. ALFFENAAR JC, Akkerman OW, van Hest R
    Statin Adjunctive Therapy for Tuberculosis Treatment.
    Antimicrob Agents Chemother. 2016;60:7004.
    >> Share

    October 2016
  211. MARCOS-ZAMBRANO LJ, Escribano P, Sanchez-Carrillo C, Bouza E, et al
    Frequency of the paradoxical effect measured using EUCAST with micafungin, anidulafungin, and caspofungin against Candida spp. isolates causing candidemia.
    Antimicrob Agents Chemother. 2016 Oct 31. pii: AAC.01584.
    >> Share

  212. WEI X, Chen P, Gao R, Li Y, et al
    Screening and characterization of the non-cyp51A mutation Afcox10 conferring azole resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2016 Oct 31. pii: AAC.02101.
    >> Share

  213. STRAUSS C, Hu Y, Coates A, Perreten V, et al
    A novel erm(44) gene variant from a human Staphylococcus saprophyticus confers resistance to macrolides, lincosamides but not streptogramins.
    Antimicrob Agents Chemother. 2016 Oct 31. pii: AAC.01655.
    >> Share

  214. ESPINEL-INGROFF A, Arendrup M, Canton E, Cordoba S, et al
    A multi-center study of method-dependent epidemiological cutoff values (ECVs) for resistance detection in Candida spp. and Aspergillus spp. to amphotericin B and echinocandins for the Etest agar diffusion method.
    Antimicrob Agents Chemother. 2016 Oct 31. pii: AAC.01792.
    >> Share

  215. ABDELRAOUF K, Nicolau DP
    Comparative In Vivo Efficacy of Tedizolid in Neutropenic versus Immunocompetent Murine Streptococcus pneumoniae Lung Infection Models.
    Antimicrob Agents Chemother. 2016 Oct 31. pii: AAC.01957.
    >> Share

  216. DUPONT HL, Wolf RA, Israel RJ, Pimentel M, et al
    Antimicrobial Susceptibility of Skin Isolates of Staphylococcus From Patients With Diarrhea-Predominant Irritable Bowel Syndrome Treated With Repeat Courses of Rifaximin.
    Antimicrob Agents Chemother. 2016 Oct 24. pii: AAC.02165.
    >> Share

  217. VILA T, Lopez-Ribot JL
    Screening the "Pathogen Box" for the Identification of Candida albicans Biofilm Inhibitors.
    Antimicrob Agents Chemother. 2016 Oct 24. pii: AAC.02006.
    >> Share

  218. FAKHIM H, Emami S, Vaezi A, Hashemi SM, et al
    In Vitro Activities of Novel Azole Compounds (ATTAF-1 and ATTAF-2) Against Fluconazole-Susceptible and -Resistant Isolates of Candida species.
    Antimicrob Agents Chemother. 2016 Oct 24. pii: AAC.01106.
    >> Share

  219. YU XQ, Robbie GJ, Wu Y, Esser MT, et al
    Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, ExtendedHalf-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults.
    Antimicrob Agents Chemother. 2016 Oct 17. pii: AAC.01020.
    >> Share

  220. SUWUNNAKORN S, Wakabayashi H, Rustchenko E
    Chromosome 5 of human pathogen Candida albicans carries multiple genes for negative control of caspofungin and anidulafungin susceptibility.
    Antimicrob Agents Chemother. 2016 Oct 10. pii: AAC.01888.
    >> Share

  221. BUTLER-LAPORTE G, Cheng MP, Cheng AP, McDonald EG, et al
    Using MRSA Screening Tests to Predict Methicillin Resistance in Staphylococcus Aureus Bacteremia.
    Antimicrob Agents Chemother. 2016 Oct 10. pii: AAC.01751.
    >> Share

  222. PHOLWAT S, Stroup S, Heysell S, Ogarkov O, et al
    Eis C-14G and C-15G mutations do not confer kanamycin resistance in M. tuberculosis.
    Antimicrob Agents Chemother. 2016 Oct 10. pii: AAC.01775.
    >> Share

  223. HAYS C, Louis M, Plainvert C, Dmytruk N, et al
    Changing epidemiology of Group B Streptococcus susceptibility to fluoroquinolones and aminoglycosides in France.
    Antimicrob Agents Chemother. 2016 Oct 10. pii: AAC.01374.
    >> Share

  224. LIAO Y, Brandt BW, Zhang M, Li J, et al
    A single nucleotide change in the promoter mutp enhances fluoride resistance of Streptococcus mutans.
    Antimicrob Agents Chemother. 2016 Oct 3. pii: AAC.01366.
    >> Share

  225. KAVANAGH KT, Saman DM, Yu Y
    Erratum for Kavanagh et al., A Perspective on How the United States Fell behind Northern Europe in the Battle against Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2016;60:6440.
    >> Share

    September 2016
  226. FAN R, Li D, Wang Y, He T, et al
    Presence of the optrA gene in methicillin-resistant Staphylococcus sciuri of porcine origin.
    Antimicrob Agents Chemother. 2016 Sep 26. pii: AAC.01591.
    >> Share

  227. WANG X, Yang S, Gu J, Deng J, et al
    Mycobacterium tuberculosis arylamine N-acetyltransferase acetylates and thus inactivates para-aminosalicylic acid.
    Antimicrob Agents Chemother. 2016 Sep 26. pii: AAC.01312.
    >> Share

  228. LI Y, Wang Y, Zhang Z, Gao H, et al
    Association between embB Codon 306 Mutations, Phenotypic Resistance Profiles and Genotypic Characterization in Clinical Mycobacterium tuberculosis Isolates from Hebei, China.
    Antimicrob Agents Chemother. 2016 Sep 26. pii: AAC.00532.
    >> Share

  229. LUNA-TAPIA A, Tournu H, Peters TL, Palmer GE, et al
    Endosomal trafficking defects can induce calcium dependent azole tolerance in Candida albicans.
    Antimicrob Agents Chemother. 2016 Sep 19. pii: AAC.01034.
    >> Share

  230. CUI L, Wang Y, Lv Y, Wang S, et al
    Nationwide Surveillance of Novel Oxazolidinone Resistance Gene optrA in Enterococcus spp. Isolates in China from 2004-2014.
    Antimicrob Agents Chemother. 2016 Sep 19. pii: AAC.01256.
    >> Share

  231. FAIS T, Cougnoux A, Dalmasso G, Laurent F, et al
    Antibiotic activity of Escherichia coli against Multiresistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2016 Sep 6. pii: AAC.00130.
    >> Share

    August 2016
  232. LEE SH, Park WB, Lee S, Park S, et al
    Association between type A blaZ Gene Polymorphism and Cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus.
    Antimicrob Agents Chemother. 2016 Aug 29. pii: AAC.01517.
    >> Share

  233. SAKOULAS G, Olson J, Yim J, Singh NB, et al
    Cefazolin and Ertapenem: A Synergistic Combination Used to Clear Persistent Staphylococcus aureus Bacteremia.
    Antimicrob Agents Chemother. 2016 Aug 29. pii: AAC.01192.
    >> Share

  234. NARAN K, Moosa A, Barry CE 3rd, Boshoff HI, et al
    Bioluminescent reporters for rapid mechanism of action assessment in tuberculosis drug discovery.
    Antimicrob Agents Chemother. 2016 Aug 29. pii: AAC.01178.
    >> Share

  235. ZHANG D, Gomez JE, Chien JY, Haseley N, et al
    Genomic analysis of the evolution of fluoroquinolone resistance in Mycobacterium tuberculosis prior to tuberculosis diagnosis.
    Antimicrob Agents Chemother. 2016 Aug 29. pii: AAC.00664.
    >> Share

  236. PINTO TC, Kegele FC, Dias CA, Barros RR, et al
    Streptococcus pneumoniae of Serotypes 9 and 14 Circulating in Brazil Over a 23-Year Period Prior to the Introduction of PCV10: Role of International Clones in the Evolution of Antimicrobial Resistance and Description of a Novel Genotype.
    Antimicrob Agents Chemother. 2016 Aug 29. pii: AAC.00673.
    >> Share

  237. LU C, Zhang Y, Chen M, Zhong P, et al
    Population Pharmacokinetics and Dosing Regimen Optimization of Meropenem in Cerebrospinal Fluid and Plasma in Patients with Meningitis after Neurosurgery.
    Antimicrob Agents Chemother. 2016 Aug 29. pii: AAC.00997.
    >> Share

  238. ABASTABAR M, Rahimi N, Meis JF, Aslani N, et al
    Potent Activities of Novel Imidazoles (lanoconazole and luliconazole) Against a Collection of Azole Resistant and Susceptible Aspergillus fumigatus strains.
    Antimicrob Agents Chemother. 2016 Aug 29. pii: AAC.01193.
    >> Share

  239. FURIN JJ, Du Bois J, van Brakel E, Chheng P, et al
    Early Bactericidal Activity of AZD5847 in Pulmonary Tuberculosis.
    Antimicrob Agents Chemother. 2016 Aug 22. pii: AAC.01163.
    >> Share

  240. ZHAO Y, Nagasaki Y, Kordalewska M, Press EG, et al
    Rapid detection of FKS-associated echinocandin resistance in Candida glabrata.
    Antimicrob Agents Chemother. 2016 Aug 22. pii: AAC.01574.
    >> Share

  241. PARK KH, Greenwood-Quaintance KE, Mandrekar J, Patel R, et al
    Activity of Tedizolid in Methicillin-Resistant Staphylococcus aureus Experimental Foreign Body-Associated Osteomyelitis.
    Antimicrob Agents Chemother. 2016 Aug 22. pii: AAC.01248.
    >> Share

  242. CHUANG YM, Dutta NK, Hung CF, Wu TC, et al
    The stringent response factors PPX1 and PPK2 play an important role in Mycobacterium tuberculosis metabolism, biofilm formation, and sensitivity to isoniazid in vivo.
    Antimicrob Agents Chemother. 2016 Aug 15. pii: AAC.01139.
    >> Share

  243. FOO CS, Lechartier B, Kolly GS, Boy-Rottger S, et al
    Characterization of DprE1-mediated benzothiazinone resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2016 Aug 15. pii: AAC.01523.
    >> Share

  244. CARUGATI M, Petti CA, Arnold C, Miro J, et al
    ANTISTAPHYLOCOCCAL beta-LACTAMS VS. VANCOMYCIN FOR THE TREATMENT OF INFECTIVE ENDOCARDITIS DUE TO METHICILLIN-SUSCEPTIBLE COAGULASE-NEGATIVE STAPHYLOCOCCI. A PROSPECTIVE COHORT STUDY FROM THE INTERNATIONAL COLLABORATION ON ENDOCARDITIS (ICE).
    Antimicrob Agents Chemother. 2016 Aug 15. pii: AAC.01531.
    >> Share

  245. NIKONENKO BV, Kornienko A, Majorov K, Ivanov P, et al
    In vitro activity of 3-triazenoindoles against Mycobacterium tuberculosis and Mycobacterium avium.
    Antimicrob Agents Chemother. 2016 Aug 8. pii: AAC.00998.
    >> Share

  246. PABST B, Pitts B, Lauchnor E, Stewart PS, et al
    Gel-entrapped Staphylococcus aureus as Models of Biofilm Infection Exhibit Growth in Dense Aggregates, Oxygen Limitation, Antibiotic Tolerance, and Heterogeneous Gene Expression.
    Antimicrob Agents Chemother. 2016 Aug 8. pii: AAC.01336.
    >> Share

  247. HO PL, Liu MC, Chow KH, Tse CW, et al
    Emergence of ileS2-carrying, multidrug-resistant plasmids in Staphylococcus lugdunensis.
    Antimicrob Agents Chemother. 2016 Aug 8. pii: AAC.00948.
    >> Share

  248. PALENCIA A, Li X, Bu W, Choi W, et al
    Discovery of novel oral protein synthesis inhibitors of Mycobacterium tuberculosis that target leucyl-tRNA synthetase.
    Antimicrob Agents Chemother. 2016 Aug 8. pii: AAC.01339.
    >> Share

  249. GU W, Guo D, Zhang L, Xu D, et al
    Synergistic Effect of Azoles and Fluoxetine against Resistant Candida albicans Attributed to Attenuating Fungal Virulence.
    Antimicrob Agents Chemother. 2016 Aug 8. pii: AAC.03046.
    >> Share

  250. WHALEY SG, Tsao S, Weber S, Zhang Q, et al
    The RTA3 gene, encoding a putative lipid translocase, influences the susceptibility of Candida albicans to fluconazole.
    Antimicrob Agents Chemother. 2016 Aug 1. pii: AAC.00732.
    >> Share

  251. CORDES H, Thiel C, Aschmann HE, Baier V, et al
    A PBPK model of isoniazid and its application in individualizing tuberculosis chemotherapy.
    Antimicrob Agents Chemother. 2016 Aug 1. pii: AAC.00508.
    >> Share

  252. WAN TW, Hung WC, Tsai JC, Lin YT, et al
    Novel structure of Enterococcus faecium-originated ermB positive Tn1546-like in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2016 Aug 1. pii: AAC.01096.
    >> Share

  253. ROCKWOOD NN, Meintjes G, Chirehwa M, Wiesner L, et al
    HIV-1 co-infection does not reduce exposure to rifampicin, isoniazid, and pyrazinamide in South African tuberculosis outpatients.
    Antimicrob Agents Chemother. 2016 Aug 1. pii: AAC.00480.
    >> Share

  254. PROSSER GA, Rodenburg A, Khoury H, de Chiara C, et al
    Glutamate racemase is the primary target of beta-chloro-D-alanine in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2016 Aug 1. pii: AAC.01249.
    >> Share

  255. LOCKE JB, Almaguer AL, Zuill DE, Bartizal K, et al
    Characterization of in vitro resistance development to the novel echinocandin, CD101, in Candida species.
    Antimicrob Agents Chemother. 2016 Aug 1. pii: AAC.00620.
    >> Share

  256. MELETIADIS J, Geertsen E, Curfs-Breuker I, Meis JF, et al
    In vitro activity of micafungin against common and rare Candida species with the EUCAST, CLSI and E-test method: Intra- and inter-laboratory agreement.
    Antimicrob Agents Chemother. 2016 Aug 1. pii: AAC.01027.
    >> Share

    July 2016
  257. SCHILCHER K, Andreoni F, Dengler Haunreiter V, Seidl K, et al
    Modulation of Staphylococcus aureus biofilm matrix by subinhibitory concentrations of clindamycin.
    Antimicrob Agents Chemother. 2016 Jul 25. pii: AAC.00463.
    >> Share

  258. REEN FJ, Phelan JP, Gallagher L, Woods DF, et al
    Exploiting interkingdom interactions for the development of small molecule inhibitors of Candida albicans biofilm formation.
    Antimicrob Agents Chemother. 2016 Jul 25. pii: AAC.00190.
    >> Share

  259. LIN GY, Chen HF, Xue YP, Yeh YC, et al
    The antimicrobial peptides P-113Du and P-113Tri function against Candida albicans.
    Antimicrob Agents Chemother. 2016 Jul 25. pii: AAC.00699.
    >> Share

  260. HUANG K, Zhang Q, Song Y, Zhang Z, et al
    Characterization of spectinomycin resistance in Streptococcus suis: two novel insights into the drug-resistance formation and dissemination mechanism.
    Antimicrob Agents Chemother. 2016 Jul 25. pii: AAC.01157.
    >> Share

  261. MODONGO C, Pasipanodya JG, Magazi BT, Srivastava S, et al
    Artificial intelligence and amikacin exposures predictive of outcome in multidrug-resistant tuberculosis patients.
    Antimicrob Agents Chemother. 2016 Jul 25. pii: AAC.00962.
    >> Share

  262. FLAMM RK, Rhomberg PR, Huband MD, Farrell DJ, et al
    In vitro activity of delafloxacin tested against isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
    Antimicrob Agents Chemother. 2016 Jul 25. pii: AAC.00941.
    >> Share

  263. GARCIA-GARCIA V, Oldfield E, Benaim G
    Inhibition of Leishmania mexicana Growth by the Tuberculosis Drug SQ109.
    Antimicrob Agents Chemother. 2016 Jul 25. pii: AAC.00945.
    >> Share

  264. SRIVASTAVA S, Modongo C, Siyambalapitiyage Dona CW, Pasipanodya JG, et al
    Amikacin optimal exposures targets in the hollow fiber system model of tuberculosis.
    Antimicrob Agents Chemother. 2016 Jul 25. pii: AAC.00961.
    >> Share

  265. HOGAN S, Zapotoczna M, Stevens NT, Humphreys H, et al
    Eradication of Staphylococcus aureus catheter-related biofilm infections using ML:8 and Citrox.
    Antimicrob Agents Chemother. 2016 Jul 25. pii: AAC.00910.
    >> Share

  266. CHEN Y, Lu Z, Zhao J, Zou Z, et al
    Epidemiology and Molecular Characterizations of Azole Resistance in Clinical and Environmental Aspergillus fumigatus from China.
    Antimicrob Agents Chemother. 2016 Jul 18. pii: AAC.01005.
    >> Share

  267. GARCIA-SOLACHE M, Lebreton F, McLaughlin RE, Whiteaker JD, et al
    Homologous recombination within large chromosomal regions facilitates acquisition of beta-lactam and vancomycin resistance in Enterococcus faecium.
    Antimicrob Agents Chemother. 2016 Jul 18. pii: AAC.00488.
    >> Share

  268. SHAH S, Dalecki AG, Malalasekera AP, Crawford CL, et al
    8-Hydroxyquinolines are boosting-agents of copper related toxicity in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2016 Jul 18. pii: AAC.00325.
    >> Share

  269. BHATTACHARYA S, Sobel JD, White TC
    A Combination fluorescent assay demonstrates increased in Efflux Pump Activity as a resistance mechanism in Azole-Resistant Vaginal Candida albicans.
    Antimicrob Agents Chemother. 2016 Jul 18. pii: AAC.01252.
    >> Share

  270. HALL SNYDER AD, Werth BJ, Nonejuie P, McRoberts JP, et al
    Fosfomycin enhances the activity of daptomycin against vancomycin-resistant Enterococcus in an in vitro pharmacokinetic/pharmacodynamic model.
    Antimicrob Agents Chemother. 2016 Jul 18. pii: AAC.00687.
    >> Share

  271. TURNER RB, Valcarlos E, Won R, Chang E, et al
    Impact of infectious diseases consultation on clinical outcomes of patients with Staphylococcus aureus bacteremia at a community health system.
    Antimicrob Agents Chemother. 2016 Jul 11. pii: AAC.00439.
    >> Share

  272. CHONG J, Quach C, Blanchard AC, Poliquin PG, et al
    Molecular epidemiology of vancomycin-intermediate heteroresistant Staphylococcus epidermidis outbreak in the neonatal intensive care unit.
    Antimicrob Agents Chemother. 2016 Jul 11. pii: AAC.00726.
    >> Share

  273. LASKARIS P, Atrouni A, Calera JA, d'Enfert C, et al
    Administration of zinc chelators improves survival of mice infected with Aspergillus fumigatus both in monotherapy and in combination with caspofungin.
    Antimicrob Agents Chemother. 2016 Jul 11. pii: AAC.00324.
    >> Share

  274. TORRES NS, Abercrombie JJ, Srinivasan A, Lopez-Ribot JL, et al
    Screening a Commercial Library of Pharmacologically Active Small Molecules Against Staphylococcus aureus Biofilms.
    Antimicrob Agents Chemother. 2016 Jul 11. pii: AAC.00377.
    >> Share

  275. MEEKER DG, Beenken KE, Mills WB, Loughran AJ, et al
    Evaluation of antibiotics active against methicillin-resistant Staphylococcus aureus based on activity in an established biofilm.
    Antimicrob Agents Chemother. 2016 Jul 11. pii: AAC.01251.
    >> Share

  276. BURNHAM JP, Burnham CA, Warren DK, Kollef MH, et al
    IMPACT OF TIME TO APPROPRIATE THERAPY ON MORTALITY IN PATIENTS WITH VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS INFECTION.
    Antimicrob Agents Chemother. 2016 Jul 11. pii: AAC.00925.
    >> Share

  277. FIGUEIRA M, Fernandes P, Pelton SI
    Efficacy of a Fourth Generation Macrolide, Solithromycin (CEM-101), for Experimental Otitis Media (EOM) Caused by Non-typeable Haemophilus influenzae (NTHi) and Streptococcus pneumoniae (SP).
    Antimicrob Agents Chemother. 2016 Jul 11. pii: AAC.00863.
    >> Share

  278. DESAI A, Kovanda L, Kowalski D, Lu Q, et al
    Population Pharmacokinetics of Isavuconazole from Phase 1 and Phase 3 (SECURE) Trial in Adults and Target Attainment in Patients with Invasive Aspergillosis and Other Filamentous Fungi.
    Antimicrob Agents Chemother. 2016 Jul 5. pii: AAC.02819.
    >> Share

  279. LEONARDELLI F, Macedo D, Dudiuk C, Cabeza MS, et al
    Aspergillus fumigatus intrinsic fluconazole resistance is due to the naturally occurring T301I substitution in Cyp51Ap.
    Antimicrob Agents Chemother. 2016 Jul 5. pii: AAC.00905.
    >> Share

  280. THOMSEN TT, Mojsoska B, Cruz JC, Donadio S, et al
    The lantibiotic NAI-107 efficiently rescues Drosophila melanogaster from infection with methicillin-resistant Staphylococcus aureus USA300.
    Antimicrob Agents Chemother. 2016 Jul 5. pii: AAC.02965.
    >> Share

  281. HURLIMANN LM, Corradi V, Hohl M, Bloemberg GV, et al
    The heterodimeric ABC transporter EfrCD mediates multidrug efflux in Enterococcus faecalis.
    Antimicrob Agents Chemother. 2016 Jul 5. pii: AAC.00661.
    >> Share

  282. MARCOS-ZAMBRANO LJ, Escribano P, Rueda C, Zaragoza O, et al
    Erratum for Marcos-Zambrano et al., Comparison between the EUCAST Procedure and the Etest for Determination of the Susceptibility of Candida Species Isolates to Micafungin.
    Antimicrob Agents Chemother. 2016;60:4429.
    >> Share

    June 2016
  283. BALLO MK, Rtimi S, Pulgarin C, Hopf N, et al
    In Vitro and In Vivo Effectiveness of an Innovative Silver-Copper Nanoparticle Coating of Catheters to Prevent Methicillin-Resistant Staphylococcus aureus Infection.
    Antimicrob Agents Chemother. 2016 Jun 27. pii: AAC.00959.
    >> Share

  284. YU X, Wang G, Chen S, Wei G, et al
    Mycobacterium tuberculosis wild-type and non-wild-type MIC distributions for the novel fluoroquinolone antofloxacin compared with ofloxacin, levofloxacin, and moxifloxacin.
    Antimicrob Agents Chemother. 2016 Jun 20. pii: AAC.00393.
    >> Share

  285. TABOR DE, Yu L, Mok H, Tkaczyk C, et al
    Staphylococcus aureus alpha toxin is conserved amongst diverse hospital respiratory isolates collected from a global surveillance study and is neutralized by a monoclonal antibody MEDI4893.
    Antimicrob Agents Chemother. 2016 Jun 20. pii: AAC.00357.
    >> Share

  286. HENDRIX AS, Spoonmore TJ, Wilde AD, Putnam NE, et al
    Repurposing the nonsteroidal anti-inflammatory drug diflunisal as an osteoprotective, anti-virulence therapy for Staphylococcus aureus osteomyelitis.
    Antimicrob Agents Chemother. 2016 Jun 20. pii: AAC.00834.
    >> Share

  287. BAXI SM, Clemenzi-Allen A, Gahbauer A, Deck D, et al
    Vancomycin Minimum Inhibitory Concentration Does Not Predict 90 Day Mortality, Readmission or Relapse in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
    Antimicrob Agents Chemother. 2016 Jun 20. pii: AAC.00658.
    >> Share

  288. WIEDERHOLD NP, Kovanda L, Najvar LK, Bocanegra R, et al
    Isavuconazole is Effective for the Treatment of Experimental Cryptococcal Meningitis.
    Antimicrob Agents Chemother. 2016 Jun 20. pii: AAC.00229.
    >> Share

  289. DISRATTHAKIT A, Prammananan T, Tribuddharat C, Thaipisuttikul I, et al
    Gyrase Mutations in Pre-extensively and Extensively Drug-resistant Tuberculosis in Thai Clinical Isolates: Insights into the Role of gyrB Mutations in Quinolone Resistance.
    Antimicrob Agents Chemother. 2016 Jun 13. pii: AAC.00539.
    >> Share

  290. LI W, Obregon-Henao A, Wallach JB, North EJ, et al
    Therapeutic potential of the Mycobacterium tuberculosis mycolic acid transporter, MmpL3.
    Antimicrob Agents Chemother. 2016 Jun 13. pii: AAC.00826.
    >> Share

  291. BAYER AS, Abdelhady W, Li L, Gonzales R, et al
    Comparative Efficacy of Tedizolid Phosphate, Linezolid and Vancomycin in a Murine Subcutaneous (subQ) Catheter-Related Biofilm Infection Model due to Methicillin-Susceptible and -Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2016 Jun 13. pii: AAC.00880.
    >> Share

  292. LI D, Hu Y, Werngren J, Mansjo M, et al
    Emergence and genetic characteristics of pyrazinamide resistant tuberculosis in China, a multi-center study.
    Antimicrob Agents Chemother. 2016 Jun 13. pii: AAC.02687.
    >> Share

  293. BOUGNOUX ME, Dannaoui E, Accoceberry I, Angoulvant A, et al
    Multicenter comparison of the Etest(R) and EUCAST for antifungal susceptibility testing of Candida isolates to micafungin.
    Antimicrob Agents Chemother. 2016 Jun 13. pii: AAC.00630.
    >> Share

  294. DEN HERTOG AL, Menting S, Pfeltz R, Warns M, et al
    PZA is active against Mycobacterium tuberculosis cultures at neutral pH with reduced temperature.
    Antimicrob Agents Chemother. 2016 Jun 6. pii: AAC.00654.
    >> Share

    May 2016
  295. ZHENG X, Zheng R, Hu Y, Werngren J, et al
    Determination of Minimum Inhibitory Concentration (MIC) Breakpoints for second-line drugs associated with clinical outcomes in multidrug-resistant tuberculosis treatment in China.
    Antimicrob Agents Chemother. 2016 May 31. pii: AAC.03008.
    >> Share

  296. LEPAK AJ, Andes DR
    In vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in the Murine Lung Infection Model.
    Antimicrob Agents Chemother. 2016 May 23. pii: AAC.00647.
    >> Share

  297. BERGLUND B, Claesson C, Nilsson LE, Hanberger H, et al
    High prevalence of heterogeneously glycopeptide intermediate coagulase-negative staphylococci in sternal wounds.
    Antimicrob Agents Chemother. 2016 May 23. pii: AAC.00217.
    >> Share

  298. HU Y, Pertinez H, Ortega-Muro F, Alameda-Martin L, et al
    Investigation of elimination rate, persistent subpopulation removal and relapse rates of Mycobacterium tuberculosis by combinations of first-line drugs in a modified Cornell mouse model.
    Antimicrob Agents Chemother. 2016 May 23. pii: AAC.02548.
    >> Share

  299. CHIEN JY, Chien ST, Chiu WY, Yu CJ, et al
    Moxifloxacin Improves Treatment Outcomes in Patients with Ofloxacin-resistant Multidrug-resistant Tuberculosis.
    Antimicrob Agents Chemother. 2016 May 23. pii: AAC.00425.
    >> Share

  300. POLLETT S, Baxi SM, Rutherford GW, Doernberg SB, et al
    Cefazolin versus nafcillin for methicillin-sensitive Staphylococcus aureus bloodstream infection: an observational study in a California tertiary medical center.
    Antimicrob Agents Chemother. 2016 May 23. pii: AAC.00243.
    >> Share

  301. ALMEIDA D, Ioerger T, Tyagi S, Li SY, et al
    Mutations in pepQ Confer Low-level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2016 May 16. pii: AAC.00753.
    >> Share

  302. LARSEN J, Clasen J, Hansen JE, Paulander W, et al
    Co-presence of tet(K) and tet(M) in livestock-associated methicillin-resistant Staphylococcus aureus CC398 is associated with increased fitness during exposure to sub-lethal concentrations of tetracycline.
    Antimicrob Agents Chemother. 2016 May 9. pii: AAC.00426.
    >> Share

  303. KAUL M, Mark L, Parhi AK, LaVoie EJ, et al
    Combining the FtsZ-Targeting Prodrug TXA709 and the Cephalosporin Cefdinir Confers Synergy and Reduces the Frequency of Resistance in Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2016 May 9. pii: AAC.00613.
    >> Share

  304. MENDES RE, Farrell DJ, Flamm RK, Talbot GH, et al
    In vitro activity of lefamulin tested against Streptococcus pneumoniae with defined serotypes, including multidrug-resistant isolates causing lower respiratory tract infections in the United States.
    Antimicrob Agents Chemother. 2016 May 9. pii: AAC.00627.
    >> Share

  305. NIGHTINGALE S, Chau TT, Fisher M, Nelson M, et al
    Efavirenz and metabolites in CSF; relationship with CYP2B6 c.516G>T genotype and perturbed blood-brain barrier due to tuberculous meningitis.
    Antimicrob Agents Chemother. 2016 May 9. pii: AAC.00280.
    >> Share

  306. CHEN HJ, Lin YT, Hung WC, Tsai JC, et al
    Distribution of SCCmec Types in Fusidic Acid-Resistant Staphylococcus epidermidis and Identification of a Novel SCC7684 Element.
    Antimicrob Agents Chemother. 2016 May 9. pii: AAC.00231.
    >> Share

    April 2016
  307. KUEHL R, Brunetto PS, Woischnig AK, Varisco M, et al
    Preventing Implant-Associated Infections by Silver Coating.
    Antimicrob Agents Chemother. 2016;60:2467-75.
    >> Share

  308. GONZALEZ D, Palazzi DL, Bhattacharya-Mithal L, Al-Uzri A, et al
    Solithromycin Pharmacokinetics in Plasma and Dried Blood Spots and Safety in Adolescents.
    Antimicrob Agents Chemother. 2016;60:2572-6.
    >> Share

    February 2016
  309. KAZMIERCZAK KM, Rabine S, Hackel M, McLaughlin RE, et al
    Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-beta-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2015;60:1067-78.
    >> Share

  310. NALE JY, Spencer J, Hargreaves KR, Buckley AM, et al
    Bacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In Vivo.
    Antimicrob Agents Chemother. 2015;60:968-81.
    >> Share

  311. KONSTANTINIDIS T, Kambas K, Mitsios A, Panopoulou M, et al
    Immunomodulatory Role of Clarithromycin in Acinetobacter baumannii Infection via Formation of Neutrophil Extracellular Traps.
    Antimicrob Agents Chemother. 2015;60:1040-8.
    >> Share

  312. TABATA Y, Takei-Masuda N, Kubota N, Takahata S, et al
    Characterization of Antifungal Activity and Nail Penetration of ME1111, a New Antifungal Agent for Topical Treatment of Onychomycosis.
    Antimicrob Agents Chemother. 2015;60:1035-9.
    >> Share

    January 2016
  313. BIDET P, Basmaci R, Guglielmini J, Doit C, et al
    Genome Analysis of Kingella kingae Strain KWG1 Reveals How a beta-Lactamase Gene Inserted in the Chromosome of This Species.
    Antimicrob Agents Chemother. 2015;60:703-8.
    >> Share

  314. ARMSTRONG ES, Farrell DJ, Palchak M, Steenbergen JN, et al
    In Vitro Activity of Ceftolozane-Tazobactam against Anaerobic Organisms Identified during the ASPECT-cIAI Study.
    Antimicrob Agents Chemother. 2015;60:666-8.
    >> Share

  315. LEPAK A, Marchillo K, VanHecker J, Azie N, et al
    Efficacy of Extended-Interval Dosing of Micafungin Evaluated Using a Pharmacokinetic/Pharmacodynamic Study with Humanized Doses in Mice.
    Antimicrob Agents Chemother. 2015;60:674-7.
    >> Share

  316. ZHANG R, Sun B, Wang Y, Lei L, et al
    Characterization of a cfr-Carrying Plasmid from Porcine Escherichia coli That Closely Resembles Plasmid pEA3 from the Plant Pathogen Erwinia amylovora.
    Antimicrob Agents Chemother. 2015;60:658-61.
    >> Share

  317. FORTINI D, Villa L, Feudi C, Pires J, et al
    Double Copies of bla(KPC-3)::Tn4401a on an IncX3 Plasmid in Klebsiella pneumoniae Successful Clone ST512 from Italy.
    Antimicrob Agents Chemother. 2015;60:646-9.
    >> Share

  318. TOM SK, Yau YC, Beaudoin T, LiPuma JJ, et al
    Effect of High-Dose Antimicrobials on Biofilm Growth of Achromobacter Species Isolated from Cystic Fibrosis Patients.
    Antimicrob Agents Chemother. 2015;60:650-2.
    >> Share

  319. SIOPI M, Neroutsos E, Zisaki K, Gamaletsou M, et al
    Bioassay for Determining Voriconazole Serum Levels in Patients Receiving Combination Therapy with Echinocandins.
    Antimicrob Agents Chemother. 2015;60:632-6.
    >> Share

  320. BALWAN A, Nicolau DP, Wungwattana M, Zuckerman JB, et al
    Clinafloxacin for Treatment of Burkholderia cenocepacia Infection in a Cystic Fibrosis Patient.
    Antimicrob Agents Chemother. 2015;60:1-5.
    >> Share

    November 2015
  321. ZHANG R, Lin D, Chan EW, Gu D, et al
    Emergence of carbapenem-resistant Serotype K1 hypervirulent Klebsiella pneumoniae (hvKP) strains in China.
    Antimicrob Agents Chemother. 2015 Nov 16. pii: AAC.02173.
    >> Share

  322. FREEMAN J, Vernon J, Vickers R, Wilcox MH, et al
    Susceptibility of Clostridium difficile isolates of varying antimicrobial resistance phenotypes to SMT19969 and 11 comparators.
    Antimicrob Agents Chemother. 2015 Nov 9. pii: AAC.02000.
    >> Share

  323. TANNER WD, Atkinson RM, Goel RK, Porucznik CA, et al
    The Effect of Meropenem Concentration on Detection of Low Numbers of Carbapenem-Resistant Enterobacteriaceae.
    Antimicrob Agents Chemother. 2015 Nov 9. pii: AAC.01904.
    >> Share

  324. CPREK JB, Gallagher JC
    Ertapenem-containing double-carbapenem therapy for the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae: a case series.
    Antimicrob Agents Chemother. 2015 Nov 9. pii: AAC.01569.
    >> Share

  325. CHIREHWA MT, Rustomjee R, Mthiyane T, Onyebujoh P, et al
    Model-based evaluation of higher doses of rifampicin using a semi-mechanistic model incorporating auto-induction and saturation of hepatic extraction.
    Antimicrob Agents Chemother. 2015 Nov 9. pii: AAC.01830.
    >> Share

  326. DOBIASOVA H, Videnska P, Dolejska M
    Complete sequences of IncU plasmids harboring quinolone resistance genes qnrS2 and aac(6' )-Ib-cr in Aeromonas spp. from ornamental fish.
    Antimicrob Agents Chemother. 2015 Nov 2. pii: AAC.01773.
    >> Share

  327. GIBSON GA, Bauer SR, Neuner EA, Bass SN, et al
    INFLUENCE OF COLISTIN DOSE ON GLOBAL CURE IN PATIENTS WITH BACTEREMIA DUE TO CARBAPENEM RESISTANT GRAM-NEGATIVE BACILLI.
    Antimicrob Agents Chemother. 2015 Nov 2. pii: AAC.01414.
    >> Share

  328. ROSSI B, Soubirou JF, Chau F, Massias L, et al
    Cefotaxime and amoxicillin/clavulanate synergism against extended-spectrum beta-lactamase producing Escherichia coli in a murine model of urinary tract infection.
    Antimicrob Agents Chemother. 2015 Nov 2. pii: AAC.02018.
    >> Share

  329. WIECZORKIEWICZ JT, Lopansri BK, Cheknis A, Osmolski JR, et al
    Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection (CDI) with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain, BI/NAP1/027.
    Antimicrob Agents Chemother. 2015 Nov 2. pii: AAC.01820.
    >> Share

    October 2015
  330. OCAMPO AM, Chen L, Cienfuegos AV, Roncancio G, et al
    High frequency of non-CG258 clones of carbapenem-resistant Klebsiella pneumoniae with distinct clinical characteristics: A two-year surveillance in five Colombian tertiary care hospitals.
    Antimicrob Agents Chemother. 2015 Oct 26. pii: AAC.01775.
    >> Share

  331. ZHANG H, Yang Q, Liao K, Ni Y, et al
    Antimicrobial Susceptibilities of Aerobic and Facultative Gram-negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China: The 2012-2013 Study for Monitoring Antimicrobial Resistance Trends (SMART).
    Antimicrob Agents Chemother. 2015 Oct 19. pii: AAC.00956.
    >> Share

  332. GUERIN F, Isnard C, Cattoir V, Giard JC, et al
    Complex Regulation Pathways of AmpC-Mediated beta-Lactam Resistance in Enterobacter cloacae complex.
    Antimicrob Agents Chemother. 2015 Oct 5. pii: AAC.01729.
    >> Share

    September 2015
  333. PIRES J, Taracila M, Bethel CR, Doi Y, et al
    In vivo Evolution of CMY-2 to CMY-33 beta-Lactamase in Escherichia coli ST131: Characterization of an Acquired Extended-Spectrum AmpC (ESAC) Conferring Resistance to Cefepime.
    Antimicrob Agents Chemother. 2015 Sep 21. pii: AAC.01804.
    >> Share

  334. SASTRY S, Clarke LG, Al-Rowais H, Querry AM, et al
    Clinical Appraisal of Fosfomycin in the Era of Antimicrobial Resistance.
    Antimicrob Agents Chemother. 2015 Sep 14. pii: AAC.01071.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016